- Home
- PHH vs PTHL Comparison
PHH vs PTHL Comparison
Compare PHH & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- PTHL
- Stock Information
- Founded
- PHH 2016
- PTHL 1998
- Country
- PHH China
- PTHL China
- Employees
- PHH N/A
- PTHL N/A
- Industry
- PHH Package Goods/Cosmetics
- PTHL
- Sector
- PHH Consumer Discretionary
- PTHL
- Exchange
- PHH Nasdaq
- PTHL Nasdaq
- Market Cap
- PHH 12.3M
- PTHL 13.5M
- IPO Year
- PHH 2024
- PTHL 2024
- Fundamental
- Price
- PHH $0.45
- PTHL $0.91
- Analyst Decision
- PHH
- PTHL
- Analyst Count
- PHH 0
- PTHL 0
- Target Price
- PHH N/A
- PTHL N/A
- AVG Volume (30 Days)
- PHH 990.2K
- PTHL 1.8M
- Earning Date
- PHH 01-01-0001
- PTHL 01-01-0001
- Dividend Yield
- PHH N/A
- PTHL N/A
- EPS Growth
- PHH N/A
- PTHL N/A
- EPS
- PHH N/A
- PTHL N/A
- Revenue
- PHH $2,768,120.00
- PTHL $448,196.00
- Revenue This Year
- PHH N/A
- PTHL N/A
- Revenue Next Year
- PHH N/A
- PTHL N/A
- P/E Ratio
- PHH N/A
- PTHL N/A
- Revenue Growth
- PHH 42.65
- PTHL N/A
- 52 Week Low
- PHH $0.41
- PTHL $0.51
- 52 Week High
- PHH $41.49
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- PHH 29.13
- PTHL 30.66
- Support Level
- PHH $0.44
- PTHL $0.82
- Resistance Level
- PHH $0.56
- PTHL $0.98
- Average True Range (ATR)
- PHH 0.06
- PTHL 0.17
- MACD
- PHH 0.28
- PTHL 0.53
- Stochastic Oscillator
- PHH 18.23
- PTHL 55.65
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.